|
| MiRNAs prognostic for basal and BRCA1 breast cancer |
|
https://doi.org/10.18632/oncotarget.26297
Bhupinder Pal, and Robin L. Anderson
|
| 35717-35718 |
|
| A triple drug combination as a novel antiglioma therapy |
|
https://doi.org/10.18632/oncotarget.26279
Yiru Zhang, Georg Karpel-Massler, and Markus D. Siegelin
|
| 35719-35720 |
|
| Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD |
|
https://doi.org/10.18632/oncotarget.26291
Kidist Ashami, John F. DiPersio, and Jaebok Choi
|
| 35721-35722 |
|
| Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure |
|
https://doi.org/10.18632/oncotarget.26267
Steven K. Libutti, Lawrence Tamarkin, and Naris Nilubol
|
| 35723-35725 |
|
| Loss of miR198 and 206 during primary tumor progression enables metastatic dissemination in human osteosarcoma |
|
https://doi.org/10.18632/oncotarget.26284
Steven Georges, Lidia Rodriguez Calleja, Camille Jacques, Melanie Lavaud, Brice Moukengue, Fernando Lecanda, Thibaut Quillard, Marta Tellez Gabriel, Pierre-François Cartron, Marc Baud’huin, François Lamoureux, Dominique Heymann, and Benjamin Ory
|
| 35726-35741 |
|
| Histologic subtyping in pathologic stage IIIA lung adenocarcinoma provides riskbased stratification for surveillance |
|
https://doi.org/10.18632/oncotarget.26285
Yusuke Takahashi, Takashi Eguchi, Koji Kameda, Shaohua Lu, Raj G. Vaghjiani, Kay See Tan, William D. Travis, David R. Jones, and Prasad S. Adusumilli
|
| 35742-35751 |
|
| Immunomodulatory effect of statins on Regulatory T Lymphocytes in human colorectal cancer is determined by the stage of disease |
|
https://doi.org/10.18632/oncotarget.26293
Belal A. Al-Husein, Bara’ Dawah, Saleem Bani-Hani, Samir M. Al Bashir, Khaled M. Al-Sawalmeh, and Nehad M. Ayoub
|
| 35752-35761 |
|
| Cytotoxicity of nimbolide towards multidrugresistant tumor cells and hypersensitivity via cellular metabolic modulation |
|
https://doi.org/10.18632/oncotarget.26299
Nuha Mahmoud, Mohamed E.M. Saeed, Yoshikazu Sugimoto, Sabine M. Klauck, Henry J. Greten, and Thomas Efferth
|
| 35762-35779 |
|
| Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes |
|
https://doi.org/10.18632/oncotarget.23200
Bo Tu, Jingfeng Bi, Dan Wu, Peng Zhao, Lei Shi, Yangxin Xie, Xin Zhang, Zhe Xu, Suxia Liu, Xinhua Wang, Xiaoxi Li, Fusheng Wang, and Enqiang Qin
|
| 35780-35789 |
|
| Attaining threshold antibody cytotoxicity for selective tumor cell destruction: an opinion article |
|
https://doi.org/10.18632/oncotarget.26271
Victor I. Seledtsov, and Galina V. Seledtsova
|
| 35790-35794 |
|
| Correction: Proteomic screening identifies the zonula occludens protein ZO1 as a new partner for ADAM12 in invadopodialike structures |
|
https://doi.org/10.18632/oncotarget.26339
Bassil Dekky, Michael Ruff, Dominique Bonnier, Vincent Legagneux, and Nathalie Théret
|
| 35795-35795 |
|
| Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.26340
Gilles Pagès
|
| 35796-35796 |
